Paperpal Prime Logo

BMC Endocrine Disorders : Impact Factor & More

eISSN: 1472-6823pISSN: 1472-6823
JournalOpen Access

Aims and Scope of BMC Endocrine Disorders

BMC Endocrine Disorders is a peer-reviewed open-access medical journal covering research in all aspects of the prevention, diagnosis, and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology. Less

Key Metrics

CiteScore
3.5
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SJR
Q3Endocrinology, Diabetes and Metabolism
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Endocrine Disorders

BMC Endocrine Disorders Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 2090
Publication Time23
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 23
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Endocrine Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Endocrine Disorders

Secondary hyperparathyroidism and lower hip bone mineral density in very old hospitalized adults: a real-world endocrine bone study
  • 6 Aug 2026
  • BMC Endocrine Disorders
Carotid plaque burden across the glycaemic spectrum: a cross-sectional study
  • 1 Aug 2026
  • BMC Endocrine Disorders
The role of body composition, irisin, and FABP4 levels in adolescent girls with polycystic ovary syndrome
  • 27 Jul 2026
  • BMC Endocrine Disorders
Association of creatinine to body weight ratio with glycemic progression and remission in Chinese adults with prediabetes: a large-scale retrospective cohort study.
  • 21 Jul 2026
  • BMC endocrine disorders
Total parathyroidectomy versus total parathyroidectomy with autotransplantation for refractory secondary hyperparathyroidism: short-term biochemical outcomes and postoperative calcium supplementation burden.
  • 21 Jul 2026
  • BMC endocrine disorders
Association and diagnostic efficacy of waist-to-height ratio with glycemic control in young and middle-aged adults with early-onset type 2 diabetes mellitus.
  • 20 Jul 2026
  • BMC endocrine disorders
Secondary hyperparathyroidism and lower hip bone mineral density in very old hospitalized adults: a real-world endocrine bone study
  • 6 Aug 2026
  • BMC Endocrine Disorders
Carotid plaque burden across the glycaemic spectrum: a cross-sectional study
  • 1 Aug 2026
  • BMC Endocrine Disorders
The role of body composition, irisin, and FABP4 levels in adolescent girls with polycystic ovary syndrome
  • 27 Jul 2026
  • BMC Endocrine Disorders
Association of creatinine to body weight ratio with glycemic progression and remission in Chinese adults with prediabetes: a large-scale retrospective cohort study.
  • 21 Jul 2026
  • BMC endocrine disorders
Total parathyroidectomy versus total parathyroidectomy with autotransplantation for refractory secondary hyperparathyroidism: short-term biochemical outcomes and postoperative calcium supplementation burden.
  • 21 Jul 2026
  • BMC endocrine disorders
Association and diagnostic efficacy of waist-to-height ratio with glycemic control in young and middle-aged adults with early-onset type 2 diabetes mellitus.
  • 20 Jul 2026
  • BMC endocrine disorders

FAQs on BMC Endocrine Disorders